Member Login
  1. Stocks
    2. /
  2. BELLUS Health Inc. (TSX: BLU)
    3. /

TSX:BLU (BELLUS Health Inc.)

About BLU

BELLUS Health Inc is a clinical-stage biopharmaceutical development company advancing novel therapeutics for conditions with a high unmet medical need, including BLU-5937, P2X3 antagonist that has the potential to be a best-in-class therapeutic for chronic cough. The company operates in one business segment namely, the development of drug candidates for health solutions.
Financial Market Data copyright © 2024 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.

    • BELLUS Health Inc. (TSX: BLU) Latest News

    Investing

    Why BELLUS Health (TSX:BLU) Stock Jumped 30% on the TSX Today!

    | Amy Legate-Wolfe

    BELLUS (TSX:BLU)(NASDAQ:BLU) stock went stratospheric with the promise of a new drug that could boost fourth-quarter revenue.

    Read more »

    Energy Stocks

    3 Bargain TSX Stocks to Buy While They’re Low

    | Christopher Liew, CFA

    Bargain deals are plenty, even if the TSX’s rally continues in July 2021. Buy shares of Canacol Energy stock, Fire…

    Read more »

    Cannabis Stocks

    3 Top Growth Stocks to Own Before They Take Off

    | Christopher Liew, CFA

    Growth investors should be eyeing the WELL Health Technologies stock, Fire & Flower stock, and BELLUS Health stock. If you…

    Read more »

    Dividend Stocks

    Got $2,000? 4 Top Stocks to Buy This Month

    | Christopher Liew, CFA

    Canadians with only $2,000 in capital can create a diversified portfolio that could deliver substantial gains. The top but affordable…

    Read more »

    Investing

    TFSA Investors: This Pharma Stock Could Rise Significantly

    | Nikhil Kumar

    Bellus Health Inc. (TSX:BLU)(NASDAQ:BLU) is a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of chronic cough.

    Read more »

    Cannabis Stocks

    2 TSX Stocks That Could Return 100% in 2021

    | Christopher Liew, CFA

    Two Canadian firms will benefit from the rapidly evolving health and wellness industry. The Bellus Health stock and Neptune Wellness…

    Read more »

    Investing

    Warren Buffett Is Betting Big on Drug Stocks

    | Christopher Liew, CFA

    Warren Buffett’s new positions in Q3 2020 are in four established pharma stocks. Bellus Health stock hasn’t taken off yet…

    Read more »

    Investing

    2 Top Oversold Stocks in the Coronavirus Market Crash

    | Christopher Liew, CFA

    Investors can watch out for the rebound of oversold assets like the Bellus Health stock and Chorus Aviation stock. The…

    Read more »

    Metals and Mining Stocks

    Canada Revenue Agency: 1 Major TFSA Mistake Could Cost You Thousands

    | Christopher Liew, CFA

    The Alacer Gold and Bellus Health stocks are showing strong earnings potential.

    Read more »

    Investing

    This Little-Known Stock Increased Over 100% in 2019!

    | Christopher Liew, CFA

    With a novel drug to treat two severe cough conditions under development, the potential gains from the Bellus Health stock…

    Read more »

    Investing

    This Biotech Stock Is Set to Climb 500%

    | Christopher Liew, CFA

    Bellus Health Inc. (TSX:BLU) could be the rising star of the biotech sector and the general market come 2020. Its…

    Read more »

    Investing

    Trudeau’s Drug Price Overhaul Threatens This Company

    | Christopher Liew, CFA

    BELLUS Health Inc. (TSX:BLU) is the latest revelation on the TSX. The healthcare stock is soaring this year. We hope…

    Read more »